At 7.6% CAGR, the South & Central America Dental Implants Market is Projected to be Worth US$ 548.68 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the South & Central America dental implants market was valued at US$ 305.72 in 2023 and is expected to reach US$ 548.68 million by 2031, registering a CAGR of 7.6% from 2023 to 2031. Strategic initiatives by companies and increasing digitization by CAD/CAM technology are among the critical factors attributed to the South & Central America dental implants market expansion.

Companies operating in the South & Central America dental implants market constantly focus on strategic developments such as product development, collaborations, agreements, and new product launches, which help them improve their sales, increase their geographic reach, and improve their capacities to cater to a larger customer base. A few strategic initiatives taken by key players operating in the South & Central America dental implants market are mentioned below:

• BioHorizons introduced Tapered Pro Conical, its first dental implant with a deep conical connection, in June 2024. Tapered Pro Conical leverages the unique and successful Tapered Pro macro design with the proven and patented CONELOG connection to provide clinicians with a predictable solution for rapid treatment options, from single tooth to entire arch. The novel implant reflects the company's commitment to developing advanced products that improve clinical performance and workflow efficiency.
• Dentsply Sirona unveiled the DS OmniTaper Implant System in March 2023, alongside the Astra Tech Implant System and the DS PrimeTaper Implant System, at the Academy of Osseointegration Annual Meeting held during March. It is an innovative solution that incorporates the proven technologies of Dentsply Sirona's EV Implant Family with new features that provide efficiency and versatility.
• In December 2022, ProSmile launched a new national brand, SmartArches Dental Implants, to broaden its product line and to provide affordable, world-class dental implant and reconstruction services.

Therefore, strategic initiatives by various companies focusing on the development of advanced implants are likely to offer growth opportunities to the South & Central America dental implants market in the coming years.

On the contrary, high costs of dental implants and dental procedures hamper the growth of South & Central America dental implants market.

Based on product, the South & Central America dental implants market is segmented into dental crowns, dental bridges, dentures, abutments and others. The dental crowns segment held 31.8% share of the South & Central America dental implants market in 2023, amassing US$ 97.18 million. It is projected to garner US$ 180.55 million by 2031 to expand at 8.1% CAGR during 2023–2031.

By material, the South & Central America dental implants market is segmented into titanium, zirconium, ceramic and others. The titanium segment held 58.7% share of the South & Central America dental implants market in 2023, amassing US$ 179.47 million. It is projected to garner US$ 328.16 million by 2031 to expand at 7.8% CAGR during 2023–2031.

By end user, the South & Central America dental implants market is segmented into hospitals and clinics, dental laboratories and others. The hospitals and clinics segment held 72.8% share of the South & Central America dental implants market in 2023, amassing US$ 222.59 million. It is projected to garner US$ 412.59 million by 2031 to expand at 8.0% CAGR during 2023–2031.

Based on country, the South & Central America dental implants market is segmented into Brazil, Argentina, and Rest of South & Central America. Brazil held 53.0% share of South & Central America dental implants market in 2023, amassing US$ 161.93 million. It is projected to garner US$ 301.84 million by 2031 to expand at 8.1% CAGR during 2023–2031.

Key players operating in the South & Central America dental implants market are DentiumUSA; Dentsply Sirona Inc; Bicon, LLC; ZimVie Inc; BioHorizons Inc; Nobel Biocare Services AG; MEGA’GEN IMPLANT CO., LTD; and Institut Straumann AG, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com